The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
C

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Year of Neoadjuvant Therapy and Checkpoint Inhibitors

By KU Hematology & Medical Oncology Review 2019 FEATURING Corey Langer
By KU Hematology & Medical Oncology Review 2019 FEATURING Corey Langer
0 views
August 2, 2019
Comments 1
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Lung
15:47
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Review of SCLC, Early & Locally Advanced NSCLC: Yea…

Feat. C. Langer
22:33
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Review of Recurrent / Metastatic NSCLC: Wild Type, KN00…

Feat. C. Langer